press releases

Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery Cambridge, UK, 12 March 2026: ELRIG, a not-for-profit, volunteer-led organisation dedicated to the global drug discovery community, today announced the keynote speakers for Advances in Cell-based Screening 2026, taking place at AstraZeneca in Gothenburg, Sweden

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform Cambridge, UK, and Cambridge, US, 9 March 2026:   Abselion, a pioneering life sciences technology company focused on simplifying biomolecule quantification, today announced that it has established a US subsidiary at The Engine in Cambridge, MA. The new location strengthens its presence in the North American life sciences ecosystem,

Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB Follows close of initial funding round with investment from Stephen Quake and Jay Flatley Irvine, California, and Daresbury, UK, 2 March 2026:   Wisdom Bioscience, Inc., a biotechnology company pioneering non-invasive oral cancer diagnostics, today announced the formation of its Scientific Advisory Board (SAB) following the close of an initial funding round. The SAB is comprised of l